All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
ARCUTIS BIOTHERAPEUTICS, INC.: Last Reported 3/31/2020

Business Address

2945 TOWNSGATE ROAD
SUITE 110
WESTLAKE VILLAGE, CA US 91361

Mailing Address

2945 TOWNSGATE ROAD
SUITE 110
WESTLAKE VILLAGE, CA US 91361
Phone Number: 805-418-5006 / State Incorporated: DE / Fiscal Year End 12/31

Balance Sheet

Date 3/31/2020 1/31/2020 12/31/2019 3/31/2019 12/31/2018
Cash and Cash Equivalents $190,893,000.00 -- $63,336,000.00 -- --
Accounts Receivable Net Current -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses and Other Current Assets $4,559,000.00 -- $5,209,000.00 -- --
Total Current Assets $253,878,000.00 -- $106,474,000.00 -- --
Property Plant and Equipement $241,000.00 -- $227,000.00 -- --
Intangible Assets Net -- -- -- -- --
Goodwill -- -- -- -- --
Other Assets $47,000.00 -- $47,000.00 -- --
Total Assets $254,392,000.00 -- $107,012,000.00 -- --
Accounts Payable $4,759,000.00 -- $1,405,000.00 -- --
Accrued Liabilities $7,281,000.00 -- $3,654,000.00 -- --
Total Current Liabilities $12,510,000.00 -- $5,550,000.00 -- --
Long Term Debt -- -- -- -- --
Additional Paid-in Capital -- -- -- -- --
Accumulated Other Comprehensive Loss $19,000.00 -- $-1,000.00 -- --
Accumulated Deficit $-94,300,000.00 -- $-66,272,000.00 -- --
Total Stockholders' Equity $241,882,000.00 -- $-65,029,000.00 $-30,539,000.00 $-23,987,000.00
Controlling Interest in Subsidiaries -- -- -- -- --
Total Liabilities and Equity $254,392,000.00 -- $107,012,000.00 -- --

Statement of Operations

Date 3/31/2020 1/31/2020 12/31/2019 3/31/2019 12/31/2018
Total Revenues -- -- -- -- --
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Research and Development $25,182,000.00 -- -- $6,203,000.00 --
Selling, General, and Administrative -- -- -- -- --
Total Operating Expenses $28,651,000.00 -- -- $6,952,000.00 --
Loss from Operations $-28,651,000.00 -- -- $-6,952,000.00 --
Loss Before Income Taxes -- -- -- -- --
Earnings Per Share Basic -- -- -- -- --
Weighted Average Shares Basic -- -- -- -- --
Earnings Per Share Diluted -- -- -- -- --
Weighted Average Shares Diluted -- -- -- -- --
Common Stock Shares Authorized 300,000,000 300,000,000 65,820,000 -- --
Common Stock Shares Outstanding 37,471,997 -- 2,120,853 -- --
Copyright 2020 PursePoor.com